Silibinin restrict cell survival and cell invasionin glioblastoma multiforme cells

سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 70

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CGC01_348

تاریخ نمایه سازی: 29 آبان 1402

چکیده مقاله:

Introduction: Glioblastoma multiforme (GBM) is the mostcommon and aggressive form of primary brain cancer in adultswith significant neurologic morbidity. Despite multimodalitytreatment regimens, GBM is associated with extremely poorprognosis and high mortality. The potential anti-neoplastic effectsof natural plant compounds have attracted widespreadinterest in cancer therapy. In this study we used silibinin, anaturally occurring flavonoid, to restrict cell proliferation andmigration of GBM cell line.Materials and Methods: In this study, we used U۸۷ cell line inRPMA۱۶۴۰ media with ۱۰% FBS. The microculture tetrazoliumtest and trypan blue exclusion assay were used to determinecell viability. We also investigated the restrictive potentials ofsilibinin on cell cycle progression, colony formation potential,and cell migration.Results: The results demonstrated that the silibinin treatmentrestrict cell proliferation in dose-dependent and time dependentmanners and also inhibited colony forming potentials. Flowcytometry analysis showed G۲/M arrest. Moreover, silibinintreatment led to reduction in cell invasion.Conclusion: The standard treatments cannot eliminate GBM.Taken together, this study indicate that silibinin could beemerging treatment modality against GBM. silibinin can alsoovercome the blood–brain barrier for effective treatment andshould be explored in clinical trials as possible therapeutic opportunityfor prolonging life of patients with GBM.

نویسندگان

Ali zekri

Department of Medical Genetics, School of Medicine, IranUniversity of Medical Sciences, Tehran, Iran

davood mohammadi

Department of Medical Genetics, School of Medicine, IranUniversity of Medical Sciences, Tehran, Iran

fatemeh abdi

Department of Medical Genetics, School of Medicine,Shahid Sadoughi University of Medical Sciences, Yazd, Iran